Literature DB >> 19343290

[Heart failure in diabetes].

Michael Resl1, Martin Hülsmann, Richard Pacher, Martin Clodi.   

Abstract

Interactions of glucose metabolism and chronic heart failure have been confirmed by many epidemiologic studies. The association of HbA1c with an increasing risk of heart failure clearly underlines the connection between both diseases. Coronary artery disease (CAD), hypertension and diabetic cardiomyopathy are long-term complications of diabetes mellitus, resulting in diabetic heart failure. Dysfunction of many regulation systems leads to specific diabetic cardiomyopathy, which has been firstly described by Rubler. A reduction in the cardiac expression of the Na-Ca exchanger pump and SERCA2a protein results in an imbalance in cardiac calcium handling. The overactive renin angiotensin aldosteron system (RAAS) also contributes to the impairment of myocardial function. Hyperlipidaemia, hpyerinsulinaemia and hyperglycaemia directly trigger diabetic cardiomyopathy. Generally chronic heart failure is a clinical diagnosis verified by blood tests like NT-proBNP and cardiac ultrasound. Recommendations on treatment of diabetic heart failure are based on subgroup analysis of the large heart failure trials.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343290     DOI: 10.1007/s10354-009-0645-0

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  95 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Influence of autonomic neuropathy upon left ventricular dysfunction in insulin-dependent diabetic patients.

Authors:  P T Monteagudo; V A Moisés; O Kohlmann; A B Ribeiro; V C Lima; M T Zanella
Journal:  Clin Cardiol       Date:  2000-05       Impact factor: 2.882

3.  Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats.

Authors:  D X Zhang; R M Fryer; A K Hsu; A P Zou; G J Gross; W B Campbell; P L Li
Journal:  Basic Res Cardiol       Date:  2001 May-Jun       Impact factor: 17.165

4.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

5.  Decreased cardiac sarcoplasmic reticulum Ca2+ -ATPase activity contributes to cardiac dysfunction in streptozotocin-induced diabetic rats.

Authors:  Xiao-Yan Zhao; Shen-Jiang Hu; Jiang Li; Yun Mou; Bao-Ping Chen; Qiang Xia
Journal:  J Physiol Biochem       Date:  2006-03       Impact factor: 4.158

6.  Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart.

Authors:  Darrell D Belke; Eric A Swanson; Wolfgang H Dillmann
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

7.  Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes.

Authors:  Fabio Fiordaliso; Ivan Cuccovillo; Roberto Bianchi; Antonio Bai; Mirko Doni; Monica Salio; Noeleen De Angelis; Pietro Ghezzi; Roberto Latini; Serge Masson
Journal:  Life Sci       Date:  2006-01-30       Impact factor: 5.037

8.  Interactions of glucose metabolism and chronic heart failure.

Authors:  M Clodi; M Resl; D Stelzeneder; G Pacini; A Tura; D Mörtl; J Struck; N G Morgenthaler; A Bergmann; M Riedl; M Anderwald-Stadler; A Luger; R Pacher; M Hülsmann
Journal:  Exp Clin Endocrinol Diabetes       Date:  2008-09-30       Impact factor: 2.949

Review 9.  Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?

Authors:  D S Bell
Journal:  Diabetes Care       Date:  1995-05       Impact factor: 19.112

10.  Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy.

Authors:  Hitoshi Yamaguchi; Junichi Yoshida; Kazuhiro Yamamoto; Yasushi Sakata; Toshiaki Mano; Noriyuki Akehi; Masatsugu Hori; Young-Jae Lim; Masayoshi Mishima; Tohru Masuyama
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

View more
  3 in total

1.  [Aerobic and strength training in patients with diabetes mellitus type 2 and heart failure].

Authors:  D Niederseer; J Niebauer
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

2.  [Diabetes mellitus].

Authors:  Peter Pietschmann
Journal:  Wien Med Wochenschr       Date:  2009

Review 3.  [Update on diabetic macroangiopathy].

Authors:  J Kunz
Journal:  Pathologe       Date:  2012-05       Impact factor: 1.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.